
Web-based Manufacturing Execution System (MES) with electronic batch record capabilities designed exclusively for pharmaceutical, biotech, cell & gene therapy, and medical device manufacturing.
POMSnet Aquila is a comprehensive, configurable Manufacturing Execution System purpose-built for life sciences manufacturing with 38 years of industry-specific development. The platform is 100% web-based, built on Microsoft .NET and HTML5, providing manufacturing execution capabilities from work order management through electronic batch record release for pharmaceutical, biotech, cell & gene therapy, and medical device facilities.
The system serves over 25,000 users across 200+ validated sites in 20 countries, including 5 of the world's 10 largest pharmaceutical companies. POMSnet Aquila is ISA-95 compliant (levels 1-4), and its Quality Management module automates FDA 21 CFR Part 11 electronic signatures and records. The other standards named on the POMSnet page - EudraLex Annex 11 and GxP, HIPAA, GAMP5, MHRA, ISO 13485 for document management, ISO 9001:2015 and ISO 27001:2013 - are requirements Validated Cloud meets as the partner that hosts POMSnet, not POMS Corporation's own certifications; POMS Corporation's position on those standards is unstated. The platform offers over 100 pre-built, pre-validated ISA-88 phases and supports more than 15 weigh and dispense methods out-of-the-box.
Core functionality includes order management with ERP integration, equipment and material management with lot-level tracking, recipe authoring, quality management with disposition workflows, personnel management with Active Directory integration, comprehensive electronic batch records with review-by-exception capabilities, and paperless worksheets and logbooks. The platform integrates with 5 million+ IIoT systems for real-time equipment data collection and supports both self-hosted on-premise and cloud/SaaS deployment models through Validated Cloud partnership.
POMSnet Falcon, a companion analytics product, provides EBR dashboards and manufacturing intelligence for production visibility and continuous improvement. The platform's commercial off-the-shelf (COTS) approach with extensive pre-validation reduces implementation time and compliance burden.
POMSnet Aquila is purpose-built exclusively for life sciences manufacturing and does not have general-purpose or non-pharma editions. The entire product is designed around GMP compliance, FDA 21 CFR Part 11 requirements, and regulated manufacturing workflows specific to pharmaceutical, biotech, cell & gene therapy, and medical device production.
POMSnet Aquila is 100% web-based, built on Microsoft .NET and HTML5 architecture, providing browser-based access from any Windows, macOS, or Linux device. The platform supports both cloud/SaaS deployment through Validated Cloud partnership and on-premise/self-hosted deployment models. The web-based architecture enables native mobile and touch-screen compatibility for floor-level device access and data entry. The system is accessible via standard web browsers without requiring VPN or additional client software.
The platform integrates with ERP systems (SAP, ERPi module), Active Directory for authentication, and 5 million+ IIoT and equipment systems for real-time data collection. RESTful APIs enable bi-directional data flow with enterprise systems. The system supports biometric authentication integration (Nymi-ready) and provides SSO capabilities for enterprise integration. All data integrity and audit trail capabilities comply with FDA 21 CFR Part 11 requirements, including tamper-proof audit logs, electronic signatures, and full data change tracking.
Pricing is not publicly disclosed. POMSnet Aquila uses a custom, contact-sales model based on customer-specific factors including facility size, user count, deployment model (cloud vs. on-premise), and module selection.
Typical implementations serve 25,000+ total users across 200+ sites globally, indicating pricing scales from mid-market to enterprise accounts. The vendor does not offer free trials. Customer engagement typically begins through sales consultation and product demonstrations for qualifying opportunities.
POMSnet Aquila implements using a Commercial Off-The-Shelf (COTS) approach with extensive pre-validation, significantly reducing implementation timelines. The platform includes 100+ pre-built, pre-validated ISA-88 phases that accelerate recipe development and reduce compliance validation burden. Implementation services include configuration, data migration, integration support, and comprehensive training for operations and management teams.
The system supports data migration from legacy systems through CSV/Excel import capabilities and direct API integration with existing enterprise systems. POMS Corporation provides validation documentation and support for customer validation activities, leveraging the pre-validated COTS components to streamline IQ/OQ/PQ processes. Customer experiences with 200+ validated sites in 20 countries demonstrate successful implementations across organizations of varying sizes, from mid-size biotech firms to multinational pharmaceutical companies with complex, multi-facility deployments.
PharmaSpotter assessment from published vendor and third-party sources. No user reviews are on file for this product.
Third-party review data is limited. Pre-built, pre-validated ISA-88 phases accelerate implementation. The exclusive life sciences focus supports pharma-specific functionality. The platform draws on 38 years of industry-specific development. FDA 21 CFR Part 11 compliance reduces validation burden. The platform serves 200+ validated customer sites in regulated environments. Integration with 5 million+ IIoT systems provides equipment connectivity.
Third-party review data is limited. Custom, contact-sales pricing without public transparency may require extensive sales engagement. The platform's implementation carries complexity. Web-based architecture may require specific browser compatibility considerations for legacy environments.
Share your experience with POMSnet Aquila anonymously. Your insights help pharmaceutical professionals make better software decisions.
Contribute Anonymous FeedbackPublicly disclosed pharmaceutical and biotech organizations
Jump to section